GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medical Net 3645.T · JPY

Communication Services · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

216

+0.93%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥6.08bn

FY2016FY2025

Net income

−¥68.1m

FY2016FY2025

Free cash flow

−¥212.4m

FY2016FY2025

Shareholders' equity

¥1.72bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥6.08bn¥5.25bn¥4.50bn¥3.75bn¥2.90bn¥2.92bn¥2.24bn¥1.74bn¥1.48bn¥1.48bn
Operating income¥98.8m¥298.3m¥379.6m¥445.1m¥331.3m¥106.4m¥176.1m¥152.7m¥123.2m¥176.1m
Net income−¥68.1m¥6.0m¥116.2m¥380.1m¥129.7m¥79.3m¥102.2m¥88.1m¥82.4m¥186.0m
Diluted earnings per share-7.640.6612.9743.4415.369.259.498.187.6417.25

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥4.08bn¥3.99bn¥3.47bn¥3.15bn¥2.11bn¥1.74bn¥2.05bn¥1.88bn¥1.77bn¥1.67bn
Cash and short-term investments¥1.46bn¥1.53bn¥1.52bn¥1.13bn¥868.7m¥605.3m¥1.04bn¥1.27bn¥1.25bn¥1.26bn
Total liabilities¥2.36bn¥2.08bn¥1.55bn¥1.45bn¥864.4m¥740.1m¥415.5m¥338.9m¥276.3m¥239.8m
Debt¥1.26bn¥1.03bn¥790.8m¥773.5m¥383.3m¥411.2m¥91.3m———
Shareholders' equity¥1.72bn¥1.91bn¥1.92bn¥1.70bn¥1.24bn¥996.5m¥1.64bn¥1.55bn¥1.50bn¥1.43bn
Shares outstanding9m9m9m9m8m9m11m11m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−¥80.9m¥119.6m¥429.1m¥342.5m¥391.9m¥78.3m¥22.2m¥116.4m¥73.3m¥311.8m
Capital spending−¥131.5m−¥32.8m−¥20.6m−¥2.2m−¥13.0m−¥8.7m−¥23.2m−¥12.3m−¥759,000−¥7.9m
Free cash flow−¥212.4m¥86.8m¥408.5m¥340.4m¥378.8m¥69.6m−¥1.0m¥104.2m¥72.6m¥303.8m
Dividends paid−¥26.8m−¥22.5m−¥35.2m−¥34.2m−¥6.2m−¥10.8m−¥10.8m−¥10.7m−¥16.2m−¥5.5m

Latest quarters

By quarter end

Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024
Revenue¥1.77bn¥1.56bn¥1.66bn¥1.51bn¥1.55bn¥1.36bn¥1.60bn¥1.31bn
Operating income¥70.1m¥24.1m¥39.3m¥11.8m¥51.5m−¥3.9m¥67.0m¥62.0m
Net income¥68.9m¥21.6m¥77.1m−¥128.3m¥18.5m−¥35.5m−¥40.0m−¥69.0m
Diluted earnings per share7.442.408.83-14.442.04-3.92-4.41-7.62
Cash from operations¥247.0m—−¥25.0m—−¥55.0m—¥250.0m—
Capital spending−¥6.0m—−¥112.0m—−¥18.0m—−¥20.0m—
Free cash flow¥241.0m—−¥137.0m—−¥73.0m—¥230.0m—
Total assets¥4.56bn¥4.25bn¥4.08bn¥4.13bn¥4.35bn¥3.89bn¥3.99bn¥3.67bn
Cash and short-term investments¥1.94bn¥1.54bn¥1.46bn¥1.40bn¥1.44bn¥1.37bn¥1.53bn¥1.44bn
Debt¥1.25bn¥1.15bn¥1.19bn¥1.23bn¥1.04bn¥901.0m¥920.0m¥922.0m
Shareholders' equity¥1.95bn¥1.87bn¥1.72bn¥1.66bn¥1.85bn¥1.84bn¥1.91bn¥1.94bn

Financial ratios

Data as of 26 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2015
Operating margin2.8%1.6%5.7%8.5%11.9%11.4%——
Net margin2.0%-1.1%0.1%2.6%10.1%4.5%——
Return on equity6.9%-4.0%0.3%6.1%22.3%10.4%——
Return on assets3.0%-1.7%0.1%3.4%12.1%6.2%——
Free cash flow yield5.0%2.3%7.2%21.2%16.4%19.7%——
Revenue growth10.8%15.6%16.7%20.2%29.0%-0.5%——
Earnings growth-301.8%-1243.6%-94.9%-69.4%193.1%63.4%——
Current ratio1.64x1.53x1.75x1.71x1.60x2.08x——
Debt to equity0.71x0.73x0.54x0.41x0.45x0.31x——
Equity ratio43.6%42.0%47.8%55.3%54.1%59.0%——
Interest coverage11.66x8.16x46.39x125.70x225.18x174.72x——
R&D as a share of sales—0.4%0.1%—0.2%0.4%0.4%2.2%
Buybacks as a share of market value0.5%-2.8%0.5%-0.9%-2.4%-3.6%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.5%15.8%—
Operating income-39.5%-1.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-39.0481.228.99.429.956.126.928.939.614.6
Price to sales0.40.60.80.91.31.51.21.52.21.8

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 28 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year3.006.002.504.004.000.751.001.00
  • 2-for-1 split · 28 May 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.